Skip to main content

Table 3 Dose differences between CT-based dose calculation and MRI bulk density assigned dose calculation

From: Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients

  Plan Max Dose D99 for Prostate D95 for Prostate
  MRI (Gy) CT (Gy) MRI (Gy) CT (Gy) MRI (Gy) CT (Gy)
Patient 1 76.61 76.97 72.45 73.70 72.65 73.90
Patient 2 82.43 79.58 77.58 76.05 77.82 76.30
Patient 3 76.17 74.01 70.24 69.78 70.60 70.18
Patient 4 74.81 75.17 70.83 69.10 71.15 70.89
Patient 5 74.25 75.13 70.54 72.01 70.73 72.09
Patient 6 78.02 77.05 73.80 73.76 73.94 73.92
Patient 7 78.78 77.46 73.67 73.42 73.81 73.55
Patient 9 81.59 79.62 76.77 75.77 76.98 75.95
Patient 10 74.97 75.25 70.63 72.03 70.70 72.13
Avg Dose Diff. −1.01% −0.11% 0.12%
STDEV 1.69% −0.34% −0.09%
P value 0.104 0.816 0.873